Results 1 to 10 of about 93,843 (327)
SERUM HSP 70 LEVELS OF CHRONIC HEPATITIS B PATIENTS ARE SUBSTANTIALLY CORRELATED WITH HBsAg [PDF]
Heat-shock protein 70 (HSP70) is a stress-induced protein that demonstrates the anti-apoptosis response that ensures the survival of cells. The aim of this study is to investigate the significant correlation of serum HSP70 levels in chronic hepatitis B ...
Awaz Saadi
doaj +1 more source
HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
Despite the availability of effective vaccines and antiviral therapy over the past two to three decades, chronic hepatitis B virus (HBV) infection remains a major global health threat as a leading cause of cirrhosis and liver cancer.
M. Moini, S. Fung
semanticscholar +1 more source
Objective To investigate the characteristics of HBV serological markers of NAT reactive blood donors under different HBsAg status. Methods NAT reactive samples, with HBsAg-, HBsAg+ /retest - and HBsAg+ by single reagent were collected from September 2021
Dequn NI+7 more
doaj +1 more source
Objective Hepatitis B virus (HBV)-specific T cells are main effector cells in the control of HBV infection and hepatitis B surface antigen (HBsAg) is suggested to be a critical factor in the impaired immune response, a hallmark of chronic HBV infection ...
E. Aliabadi+9 more
semanticscholar +1 more source
The role of Recombinant interleukin-2 in the treatment of patients with chronic hepatitis B.
Dysregulated immune response occurring in chronic hepatitis B prevents the virus elimination and contributes to progression of the infectious process.
Anastasiya F. Novikova+2 more
doaj +1 more source
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
Abstract Objectives Detection of hepatitis B surface antigen (HBsAg) plays an important role in the screening and diagnosis of hepatitis B virus (HBV) infections. There is a need of highly sensitive assays with an improved lower limit of detection (LoD).
Ekta Gupta+6 more
openaire +2 more sources
How does the immunogenicity of hepatitis B vaccine change over the years in childhood?
Hepatitis B is the leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. The incidence of HBV infection has significantly decreased with hepatitis B vaccination. Hepatitis B vaccine is administered to children at 0, 1 and
Gulsum Iclal Bayhan+3 more
doaj +1 more source
PreHevbrio: the first approved 3-antigen hepatitis B vaccine
Introduction Hepatitis B remains a major cause of death and morbidity worldwide. Universal childhood immunization programs have been very successful, but many adults remain unprotected or are not optimally protected.
Timo Vesikari+3 more
doaj +1 more source
Hepatitis B infection among hemodialysis patients in Al-Jazirah State: a seroepidemiological survey
Hemodialysis patients are more susceptible to HBV infection because they have low immunity and can be inflicted through an improperly sterilized machine or through a tainted blood transfusion.
Moglad Ehssan H. O.+2 more
doaj +1 more source
Recommendations promoted worldwide have suggested a period of protection lasting more than 20 years against hepatitis B (HB) following primary immunization. Starting in 1987, universal HB vaccinations were carried out in Long An County, Guangxi Province,
Zhigang Zheng+8 more
doaj +1 more source